TickerFacts.

Biolife Solutions Inc (BLFS): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2023-12-31, 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$33.04M
As of 2025-12-31
$24.00M
As of 2026-06-30
$91.54M2010-12-31: $3.2K2011-12-31: $16.9K2012-12-31: $196.5K2013-12-31: $156.3K2014-12-31: $2.54M2015-12-31: $2.17M2016-12-31: $1.41M2017-12-31: $6.66M2018-03-30: $7.03M2018-03-31: $7.03M2018-06-30: $14.17M2018-09-30: $32.38M2018-12-31: $30.66M2019-03-30: $31.82M2019-03-31: $31.82M2019-06-30: $19.62M2019-09-30: $21.20M2019-12-31: $6.45M2020-12-31: $90.40M2021-12-31: $69.86M2022-12-31: $19.44M2023-12-31: $27.90M2024-12-31: $91.54M2025-12-31: $33.04M$33.04M
2010-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$33.04M-63.9%2026-02-26, Balance as of period end
2024-12-31$91.54Mn/c2026-02-26, Balance as of period end
2023-12-31$27.90Mn/c2025-03-03, Balance as of period end
2022-12-31$19.44M-72.2%2024-02-29, Balance as of period end
2021-12-31$69.86M-22.7%2023-03-31, Balance as of period end
2020-12-31$90.40Mn/m2022-03-31, Balance as of period end
2019-12-31$6.45Mn/a2022-03-31, Balance as of period end
2019-09-30$21.20Mn/a2020-05-15, Balance as of period end
2019-06-30$19.62Mn/a2020-05-15, Balance as of period end
2019-03-31$31.82Mn/a2020-05-15, Balance as of period end
2019-03-30$31.82Mn/a2020-05-15, Balance as of period end
2018-12-31$30.66Mn/a2020-05-15, Balance as of period end
2018-09-30$32.38Mn/a2020-05-15, Balance as of period end
2018-06-30$14.17Mn/a2020-05-15, Balance as of period end
2018-03-31$7.03Mn/a2020-05-15, Balance as of period end
2018-03-30$7.03Mn/a2020-05-15, Balance as of period end
2017-12-31$6.66M+374.0%2019-03-15, Balance as of period end
2016-12-31$1.41M-35.3%2018-03-09, Balance as of period end
2015-12-31$2.17M-14.4%2017-03-15, Balance as of period end
2014-12-31$2.54Mn/m2016-02-25, Balance as of period end
2013-12-31$156.3K-20.5%2015-03-12, Balance as of period end
2012-12-31$196.5Kn/m2014-02-12, Balance as of period end
2011-12-31$16.9K+425.2%2013-03-29, Balance as of period end
2010-12-31$3.2Kn/a2012-03-29, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$33.04M-63.9%
Vaso Corp (VASO)2025-12-31$35.05M+33.4%
Ceribell, Inc. (CBLL)2025-12-31$40.48M-79.2%
Outset Medical, Inc. (OM)2025-12-31$35.01M-71.8%
Electromed, Inc. (ELMD)2026-06-30$20.45M+33.8%
Iridex Corp (IRIX)2026-01-03$6.03M+152.5%
Axogen, Inc. (AXGN)2025-12-31$35.55M+29.0%
Stereotaxis, Inc. (STXS)2025-12-31$13.42M+9.9%
electroCore, Inc. (ECOR)2025-12-31$7.04M+90.1%

Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗